Markets & Regulations

(Image: Getty/DenKuvaiev)

The next act: ACRO, R&D Caucus moving forward with second Cures bill

By Melissa Fassbender

ACRO is collaborating with the Congressional Research and Development Caucus and others to bring forth a new Cures bill focused, in part, on patient engagement, data, and digital health – with draft legislation anticipated early next year.

Outsourcing-Pharma roundup October ‘19

People on the Move: Outsourcing-Pharma roundup October ‘19

By Melissa Fassbender

This month’s people on the move includes a new therapeutic lead at Advanced Clinical, with plans to create a network of investigation sites, as well as CEOs at AIT Bioscience and Pharm-Olam, who discuss plans for moving forward.

(Image: Getty/z_wei)

Sponsors need to understand and prepare for CCPA: Greenphire

By Melissa Fassbender

California’s data privacy law will provide clinical trial participants with confidence that their information will not be misused – though additional clarity is needed as the pharmaceutical industry faces mounting pressure to increase transparency.

People on the Move: Outsourcing-Pharma roundup September ‘19

People on the Move: Outsourcing-Pharma roundup September ‘19

By Melissa Fassbender

Phastar is building up its data science group as AI and machine learning ‘are rapidly modernizing clinical trials’ and Synteract boosts its centers of development in oncology and rare/orphan diseases, among other people on the move this month.

Follow us

Products

View more

Webinars